Real-time enrollment status for this chronic urticaria clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT06445023 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Chronic Urticaria |
| Phase | Clinical Trial |
| Target Enrollment | 915 participants |
| Active Locations | 61 sites in the US |
| Sponsor | Celldex Therapeutics |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT06445023 is currently active_not_recruiting participants. This clinical trial study for chronic urticaria is not currently accepting new participants at 61 locations across the United States. The study is sponsored by Celldex Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06445023 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 61 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06445023 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.